Press Releases More Year None2024202320222021202020192018201720162015 Date Title 2/12/24 G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee 1/8/24 G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference 1/3/24 G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference 1/2/24 G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 14 of 14